HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroaki Kajiyama Selected Research

Biomarkers (Surrogate Marker)

4/2024Spatial distribution of tumor-resident macrophages as predictive biomarkers in endometrial cancer.
4/2024Real-world data of poly (ADP-ribose) polymerase inhibitor response in Japanese patients with ovarian cancer.
12/2023Mean platelet volume as a potential biomarker for survival outcomes in ovarian clear cell carcinoma.
11/2023Serum miRNA as a predictive biomarker for ovarian reserve after endometrioma-cystectomy.
10/2023The sarcopenia index measured using the lumbar paraspinal muscle is associated with prognosis in endometrial cancer.
8/2023Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumors.
1/2023Identifying high-grade serous ovarian carcinoma-specific extracellular vesicles by polyketone-coated nanowires.
1/2023Preoperative serum microRNAs as potential prognostic biomarkers in ovarian clear cell carcinoma.
1/2023The prognostic significance of DDIT4 in endometrial cancer.
12/2021Placental Leucine Aminopeptidase as a Potential Specific Urine Biomarker for Invasive Ovarian Cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroaki Kajiyama Research Topics

Disease

142Neoplasms (Cancer)
05/2024 - 01/2003
56Carcinoma (Carcinomatosis)
04/2024 - 01/2002
49Ovarian Neoplasms (Ovarian Cancer)
05/2024 - 04/2005
28Ovarian Epithelial Carcinoma
01/2023 - 04/2003
25Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2023 - 03/2008
21Neoplasm Metastasis (Metastasis)
07/2023 - 07/2004
17Endometrial Neoplasms (Endometrial Cancer)
04/2024 - 08/2003
12Choriocarcinoma
09/2023 - 08/2003
10Ascites
11/2023 - 11/2007
10Adenocarcinoma
08/2023 - 01/2003
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2023 - 05/2004
7Residual Neoplasm
05/2024 - 10/2011
7Inflammation (Inflammations)
04/2024 - 01/2016
7Endometriosis
11/2023 - 01/2006
7Rupture
01/2021 - 01/2009
7Endometrioid Carcinoma
01/2014 - 03/2003
6Lymphatic Metastasis
01/2023 - 01/2005
5Glioblastoma (Glioblastoma Multiforme)
01/2021 - 01/2016
4Leiomyosarcoma
05/2023 - 08/2013
4Pre-Eclampsia (Preeclampsia)
01/2023 - 11/2021
4Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
04/2021 - 05/2012
4Teratoma (Teratoid Tumor)
12/2019 - 05/2012
4Mucinous Adenocarcinoma (Mucinous Carcinoma)
03/2019 - 10/2006
3Myoma
02/2024 - 01/2023
3Carcinogenesis
02/2024 - 03/2005
3Hypoxia (Hypoxemia)
01/2023 - 01/2008
3Infertility (Sterility)
12/2022 - 10/2020
3Postpartum Depression (Post-Natal Depression)
07/2022 - 01/2022
3Melanoma (Melanoma, Malignant)
12/2020 - 02/2010
3Lung Neoplasms (Lung Cancer)
01/2020 - 04/2010

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
10/2023 - 04/2003
16Biomarkers (Surrogate Marker)IBA
04/2024 - 03/2014
15Paclitaxel (Taxol)FDA LinkGeneric
05/2024 - 11/2004
15MicroRNAs (MicroRNA)IBA
02/2024 - 08/2014
14PlatinumIBA
05/2024 - 11/2004
14Cisplatin (Platino)FDA LinkGeneric
04/2024 - 03/2006
11EnzymesIBA
12/2022 - 04/2003
11Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
02/2010 - 05/2002
10Peptides (Polypeptides)IBA
01/2022 - 03/2003
10Plasma GasesIBA
01/2021 - 06/2016
10Complementary DNA (cDNA)IBA
11/2009 - 04/2003
9Carboplatin (JM8)FDA LinkGeneric
05/2024 - 11/2004
9Indicators and Reagents (Reagents)IBA
01/2023 - 04/2008
8Small Interfering RNA (siRNA)IBA
05/2020 - 01/2007
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2018 - 12/2003
8Angiotensin IIIBA
05/2011 - 08/2003
7ParaffinIBA
12/2019 - 01/2004
6Ringer's LactateIBA
02/2024 - 11/2016
6leucyl-cystinyl aminopeptidaseIBA
12/2021 - 04/2003
6Cadherins (E-Cadherin)IBA
01/2020 - 05/2003
5Poly(ADP-ribose) Polymerase InhibitorsIBA
05/2024 - 01/2023
5CytokinesIBA
01/2024 - 01/2016
5DNA (Deoxyribonucleic Acid)IBA
06/2023 - 05/2014
5SolutionsIBA
02/2023 - 11/2016
5Formaldehyde (Formol)FDA Link
12/2019 - 01/2004
5Capsules (Microcapsules)IBA
03/2019 - 12/2011
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 05/2016
5GlypicansIBA
09/2014 - 01/2010
4Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
04/2024 - 01/2023
4AcidsIBA
11/2023 - 03/2018
4Phosphotransferases (Kinase)IBA
07/2023 - 03/2020
4Hormones (Hormone)IBA
01/2022 - 02/2009
4Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
06/2010 - 04/2008
4Neprilysin (Neutral Endopeptidase)IBA
03/2005 - 04/2003
4Oxytocin (Pitocin)FDA LinkGeneric
08/2004 - 04/2003
3niraparibIBA
04/2024 - 07/2023
3IronIBA
02/2024 - 10/2020
3Fibronectins (Fibronectin)IBA
01/2024 - 02/2009
3Antineoplastic Agents (Antineoplastics)IBA
01/2024 - 03/2020
3Therapeutic UsesIBA
11/2023 - 05/2017
3Bevacizumab (Avastin)FDA Link
10/2023 - 12/2019
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
08/2023 - 03/2020
3RNA (Ribonucleic Acid)IBA
01/2023 - 12/2019
3Glucose (Dextrose)FDA LinkGeneric
12/2022 - 01/2007
3taxaneIBA
03/2022 - 10/2011
3AminopeptidasesIBA
01/2022 - 12/2003
3SpectrinIBA
05/2020 - 01/2012
3ChemokinesIBA
01/2020 - 01/2007
3Messenger RNA (mRNA)IBA
03/2018 - 01/2008
3ubenimexIBA
03/2008 - 05/2007
3Chemokine CXCL12IBA
01/2008 - 07/2004
3Endothelin-1 (Endothelin 1)IBA
03/2005 - 08/2004
3Leucyl Aminopeptidase (Peptidase S)IBA
01/2005 - 08/2003
3Peptide Hydrolases (Proteases)FDA Link
08/2004 - 05/2004

Therapy/Procedure

44Drug Therapy (Chemotherapy)
05/2024 - 11/2004
39Therapeutics
05/2024 - 04/2005
13Hysterectomy
09/2023 - 01/2006
12Lymph Node Excision (Lymph Node Dissection)
07/2023 - 06/2008
7Radiotherapy
08/2023 - 03/2008
6Immunotherapy
10/2023 - 09/2014
6Adjuvant Chemotherapy
03/2022 - 12/2011
5Trachelectomy
11/2023 - 12/2016
5Cystectomy
11/2023 - 04/2013
5Chemoradiotherapy
08/2023 - 05/2016
4Neoadjuvant Therapy
07/2023 - 01/2004
4Salpingo-oophorectomy
05/2022 - 01/2006
4Cytoreduction Surgical Procedures
01/2019 - 01/2006
3Combination Drug Therapy (Combination Chemotherapy)
10/2023 - 04/2021
3Aftercare (After-Treatment)
01/2022 - 01/2012
3Operative Surgical Procedures
12/2021 - 01/2006